問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
邵幼雲
下載
2020-11-01 - 2030-08-22
Condition/Disease
Cancer
Test Drug
Nivolumab
Participate Sites4Sites
Recruiting4Sites
2022-07-01 - 2028-05-31
Colorectal Neoplasms
BMS-986213 (Relatlimab-Nivolumab FDC)
Participate Sites5Sites
Recruiting5Sites
2022-06-01 - 2029-01-31
2020-12-15 - 2026-01-30
2019-11-30 - 2026-09-30
xxxxxx
Participate Sites9Sites
Recruiting9Sites
2025-12-15 - 2028-06-29
Participate Sites3Sites
Recruiting3Sites
2021-03-01 - 2026-12-30
Participate Sites6Sites
Not yet recruiting3Sites
2022-06-01 - 2026-12-31
Recruiting6Sites
2020-06-01 - 2024-05-31
Advanced Solid Tumors and Lymphoma
NIZ985PDR001
Participate Sites1Sites
Recruiting1Sites
2024-12-01 - 2031-05-31
全部
